Team

Andrew is responsible for Nomura’s UK mid-cap private equity investment activities. On his return from Hong Kong in 2001 Andrew assumed the management of Nomura’s $300m portfolio of over 50 technology investments. In 2003 he started Nomura’s second technology fund with investments in netForensics, Revivio, Meriton, Visage, Operax and Compellent In 2005 he diversified the team’s activities to include Healthcare Services and later Business Services.

He has served on a number of boards including WGSN, Arraycomm, Revivio, netForensics, Lifeways, Nations Healthcare and Compellent. Prior to Nomura he worked for SG Securities and Bankers Trust.

During his 25 year career Andrew has been involved in various investment banking roles in London, Hong Kong and Los Angeles including M&A, equity capital markets and corporate restructuring.

Within Nomura, Shay is responsible for identifying and executing investments in the healthcare and business services sectors.

Shay completed Nomura’s investments in Nations Healthcare and Lifeways Community Care and is responsible for developing Nomura’s investments in Healthcare and Business Services.

He served on the board of Lifeways Community Care and was an observer to the board of Nations Healthcare.

Shay qualified as a Chartered Accountant in London with Arthur Andersen and joined Nomura from Deloitte & Touche Corporate Finance.

Shay was a lecturer in management at the University of London and holds a first class degree in economics from Cambridge University

Within Nomura, Mark is responsible for portfolio management and deal origination from a clinical perspective. Mark is an expert on clinical workforce dynamics and has lectured on healthcare policy.

Mark has an undergraduate degree in Experimental Pathology from London University and a Medical degree from Oxford University.

He has worked extensively for the British, Australian and New Zealand Health Services and is an experienced clinician in Internal Medicine and Critical Care.

He has been awarded Membership to the Royal Colleges of Physicians and Paediatrics and Child Health and holds an Executive MBA from the London Business School.